| Term 
 
        | Microsomal and Non-microsomal |  | Definition 
 
        | 	Microsomal •	CYP’s
 	Non-microsomal
 •	Oxidases
 •	Dehysrogeases
 |  | 
        |  | 
        
        | Term 
 
        | Pre-systemic Drug Metabolism |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 	Systemic circulation 	Other organs
 |  | 
        |  | 
        
        | Term 
 
        | Drug Metabolism : Enzymes: CYPs |  | Definition 
 
        | o	Organ Location: Liver, kidneys, lungs and intestine o	Cellular Location: Endoplasmic reticulum (ER)
 o	Catalyzes oxidation reactions
 o	 Classified based on family, subfamily and isoforms
 |  | 
        |  | 
        
        | Term 
 
        | Polymorphic CYPs relevant for drug metabolism |  | Definition 
 
        | o	1A2 o	2A6
 o	2C8
 o	2C9
 o	2C19
 o	2D6
 o	2E1
 	Asian variants
 	Effected by smoking
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 	Introduction of polar functional groups 	 Increase in water solubility
 	 Drugs could be eliminated after Phase I if or could undergo Phase II reactions
 	Examples
 •	Oxidation
 o	Hydroxylaton
 o	Oxidation
 o	Dealkylation
 o	Deamination
 •	Reduction
 •	 Hydrolysis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 	Involves conjugation with endogenous molecules such as amino acids, sulfate, glutathione etc. 	 The purpose is to further increase water solubility (exception : methylation)
 	Examples
 •	Methylation
 •	Glycine conjugation
 •	Sulfation
 •	Glutathione conjugation
 •	Acetylation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 	95% of oxidation reactions are catalyzed by CYP enzymes 	Non-CYP enzymes catalyzing oxidation are:
 •	Alcohol dehydrogenase
 •	Aldehyde dehydrogenase
 •	Flavin containing monooxygenase –FMO (Important enzyme  for oxidation of xenobiotics containing N or S)
 •	 Xanthine Oxidase
 o	Treatment of gout (target)
 •	Amine Oxidase
 •	Aromatases
 o	Target for best and ovarian cancer
 |  | 
        |  | 
        
        | Term 
 
        | Oxidation : Hydroxylation |  | Definition 
 
        | 	Introduction of hydroxyl groups to an aliphatic or aromatic structure •	CYP2C8/CYP2C9  - aliphilic (Adds primary or secondary OH)
 •	CYP2C9 – aromatic (Adds to least hindered
 |  | 
        |  | 
        
        | Term 
 
        | Oxidation : N-Oxidation and S-Oxidation |  | Definition 
 
        | 	N and S groups are oxidized to form corresponding oxides 	 Usually oxide derivative undergoes further reactions
 	N- oxidation
 •	FMO
 	S- oxidation
 •	FMO
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 	Involves losing of alkyl group attached to N, O or S •	CH3, CH3CH2, CH3CH2CH2, (CH3)2CH2, CH3CH2CH2CH2
 •	Des
 o	Desmethyl – Loss of a methyl
 •	Nor
 o	Same as des
 •	N- Dealkylation – CYP2C19
 •	O-Dealkylation – CYP2D6
 •	S-Dealkylation – CYP
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 	Involves losing of primary amine group and formation of ketones or acids 	 Commonly seen in metabolism of neurotransmitters
 	 Catalyzed by Monoamine Oxidases (MAO)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 	Not as common as oxidative reactions 	 Generally the CYP450 enzymes are used in the presence of NADPH
 	 Three major types of reduction reactions pertinent to drug metabolism:
 •	Azo-reduction
 o	Azoreductase a.k.a. CYP450’s
 o	N=N -> NH2 + H2N
 •	Niro-reduction
 o	NO2 -> NH2
 •	Reduction of ketones
 o	=O -> OH
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 	Common metabolic transformation of drugs containing esters or amides 	Esterases and amidases are mainly responsible for the hydrolysis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 	Adds Methyl group to OH •	OH -> OCH3
 •	Methylation and acylation are phase II reactions but decreases water solubility
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Conjugation with Glutathione (GSH) |  | Definition 
 
        | 	3. Glutathione Conjugation: •	Involves replacement of electrophilic substitution in xenobiotic with glutathione
 •	 GSH also acts as a free radical scavenger
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 	Commonly seen in the biotransformation of steroid hormones, catecholamine neurotransmitters, bile acids and phenolic drugs |  | 
        |  | 
        
        | Term 
 
        | Glucuronic acid conjugation |  | Definition 
 
        | most common route of phase II metabolism 	Adds hydrophilic groups to “handles” created in Phase I metabolism
 	Glucuronides are less reactive/active than their parent molecules in most cases
 	Typically, –OH, -NH2 groups undergo this process (sometimes COOH)
 	Readily eliminated (mainly by kidneys)
 	UDP= Uridine diphosphate
 	UGT= Uridine Glucoronyl transferase
 	If added to a carboxylic acid, dissolves in urine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 	Adds AC to 	NH2 -> H3CCON
 	Fast Acetylators and slow acetylators
 	Methylation and acylation are phase II reactions but decreases water solubility
 |  | 
        |  | 
        
        | Term 
 
        | Drug Metabolism : Chemical Pathways: Phase II |  | Definition 
 
        | o	Conjugation Reactions o	Enzymes are called as transferases
 o	Methylation
 o	Glycine conjugation
 o	Conjugation with Glutathione (GSH)
 o	Sulfation
 o	Glucoridination
 o	Acetylation
 |  | 
        |  |